4.7 Article

Inflammatory chemokine (C-C motif) ligand 8 inhibition ameliorates peritoneal fibrosis

期刊

FASEB JOURNAL
卷 37, 期 1, 页码 -

出版社

WILEY
DOI: 10.1096/fj.202200784R

关键词

apoptosis; chemokine (C-C motif) ligand 8 (CCL8); fibrosis; inflammation; peritoneal dialysis

向作者/读者索取更多资源

We investigated the levels of chemokine CCL8 in PD effluent and serum, as well as its tissue expression, and found an association with peritoneal fibrosis. We also found that CCL8 levels significantly increased with the duration of PD and were correlated with peritoneal transport parameters. In a mouse model, CCL8 blockade improved peritoneal inflammation and fibrosis.
Peritoneal fibrosis (PF) is an irreversible complication of peritoneal dialysis (PD) that leads to loss of peritoneal membrane function. We investigated PD effluent and serum levels and the tissue expression of chemokine (C-C motif) ligand 8 (CCL8) in patients with PD. Additionally, we investigated their association with PF in a mouse model. Eighty-two end-stage renal disease (ESRD) patients with PD were examined. CCL8 levels were measured via enzyme-linked immunosorbent assays in PD effluents and serum and analyzed with peritoneal transport parameters. Human peritoneal mesothelial cells (hPMCs) were obtained from the PD effluents of 20 patients. Primary cultured hPMCs were treated with recombinant (r) transforming growth factor (TGF)-beta, and CCL8 expression was assessed via western blotting. As the duration of PD increased, the concentration of CCL8 in PD effluents significantly increased. Correlations between peritoneal transport parameters and dialysate CCL8 levels were observed. Western blotting analysis showed that CCL8 was upregulated via rTGF-beta treatment, accompanied by increases in markers of inflammation, fibrosis, senescence, and apoptosis in hPMCs after induction of fibrosis with rTGF-beta. Anti-CCL8 monoclonal antibody (mAb) treatment suppressed the rTGF-beta-induced increase in all analyzed markers. Immunohistochemical analysis revealed that CCL8 along with fibrosis- and inflammation-related markers were significantly increased in the PF mouse model. Functional blockade of CCL8 using a CCR8 inhibitor (R243) abrogated peritoneal inflammation and fibrosis in vivo. In conclusion, high CCL8 levels in PD effluents may be associated with an increased risk of PD failure, and the CCL8 pathway is associated with PF. CCL8 blockade can ameliorate peritoneal inflammation and fibrosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据